ALLOGENE THERAPEUTICS INC's ticker is and the CUSIP is 019770906. A total of 3 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,829 | +8.6% | 33,700 | +70.2% | 0.00% | – |
| Q2 2023 | $98,406 | +848.6% | 19,800 | +842.9% | 0.00% | – |
| Q1 2023 | $10,374 | -21.5% | 2,100 | 0.0% | 0.00% | – |
| Q4 2022 | $13,209 | -86.2% | 2,100 | -76.4% | 0.00% | – |
| Q3 2022 | $96,000 | -35.6% | 8,900 | -32.1% | 0.00% | – |
| Q2 2022 | $149,000 | +73.3% | 13,100 | +39.4% | 0.00% | – |
| Q1 2022 | $86,000 | -63.2% | 9,400 | -40.1% | 0.00% | – |
| Q4 2021 | $234,000 | +151.6% | 15,700 | +336.1% | 0.00% | – |
| Q3 2021 | $93,000 | -58.5% | 3,600 | -58.1% | 0.00% | – |
| Q2 2021 | $224,000 | +17.3% | 8,600 | +59.3% | 0.00% | – |
| Q1 2021 | $191,000 | +282.0% | 5,400 | +170.0% | 0.00% | – |
| Q4 2020 | $50,000 | +31.6% | 2,000 | +100.0% | 0.00% | – |
| Q3 2020 | $38,000 | -25.5% | 1,000 | -16.7% | 0.00% | – |
| Q2 2020 | $51,000 | +41.7% | 1,200 | -14.3% | 0.00% | – |
| Q4 2019 | $36,000 | -40.0% | 1,400 | -36.4% | 0.00% | – |
| Q3 2019 | $60,000 | +11.1% | 2,200 | +10.0% | 0.00% | – |
| Q2 2019 | $54,000 | +42.1% | 2,000 | +53.8% | 0.00% | – |
| Q1 2019 | $38,000 | – | 1,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,100 | $10,374 | 0.00% |
| SIMPLEX TRADING, LLC | 16,100 | $79 | 0.00% |